BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24912965)

  • 1. The morbidity and associated risk factors of cancer in chronic liver disease patients with diabetes mellitus: a multicenter field survey.
    Kawaguchi T; Kohjima M; Ichikawa T; Seike M; Ide Y; Mizuta T; Honda K; Nakao K; Nakamuta M; Sata M
    J Gastroenterol; 2015 Mar; 50(3):333-41. PubMed ID: 24912965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease.
    Donadon V; Balbi M; Ghersetti M; Grazioli S; Perciaccante A; Della Valentina G; Gardenal R; Dal Mas M; Casarin P; Zanette G; Miranda C
    World J Gastroenterol; 2009 May; 15(20):2506-11. PubMed ID: 19469001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulin.
    Donadon V; Balbi M; Casarin P; Vario A; Alberti A
    World J Gastroenterol; 2008 Oct; 14(37):5695-700. PubMed ID: 18837086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease.
    Donadon V; Balbi M; Mas MD; Casarin P; Zanette G
    Liver Int; 2010 May; 30(5):750-8. PubMed ID: 20331505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
    Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
    Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection.
    Kawaguchi T; Taniguchi E; Morita Y; Shirachi M; Tateishi I; Nagata E; Sata M
    Liver Int; 2010 Mar; 30(3):479-86. PubMed ID: 20040053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiazolidinediones, alpha-glucosidase inhibitors, meglitinides, sulfonylureas, and hepatocellular carcinoma risk: A meta-analysis.
    Arvind A; Memel ZN; Philpotts LL; Zheng H; Corey KE; Simon TG
    Metabolism; 2021 Jul; 120():154780. PubMed ID: 33891949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Viral Hepatitis Signifies the Association of Premixed Insulin Analogues with Liver Cancer Risks: A Nationwide Population-Based Study.
    Chiang CH; Kuo CS; Lin WW; Su JH; Chen JD; Huang KC
    Int J Environ Res Public Health; 2019 Jun; 16(12):. PubMed ID: 31200528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases.
    Wang CP; Kuhn J; Shah DP; Schmidt S; Lam YF; MacCarthy D; Tenner L; Ramirez AG
    Cancer Med; 2019 Jun; 8(6):3206-3215. PubMed ID: 30993905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
    Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
    Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparity in liver cancer incidence and chronic liver disease mortality by nativity in Hispanics: The Multiethnic Cohort.
    Setiawan VW; Wei PC; Hernandez BY; Lu SC; Monroe KR; Le Marchand L; Yuan JM
    Cancer; 2016 May; 122(9):1444-52. PubMed ID: 26916271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes is associated with chronic liver disease and liver cancer in the adult population of Puerto Rico.
    Ortiz AP; Romero C; Disdier O; Santana E; Torres M; Torres EA; Pérez CM
    P R Health Sci J; 2011 Sep; 30(3):132-4. PubMed ID: 21932714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma.
    Sahasrabuddhe VV; Gunja MZ; Graubard BI; Trabert B; Schwartz LM; Park Y; Hollenbeck AR; Freedman ND; McGlynn KA
    J Natl Cancer Inst; 2012 Dec; 104(23):1808-14. PubMed ID: 23197492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and pharmacokinetics of metformin in patients with chronic liver disease.
    Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO
    Aliment Pharmacol Ther; 2020 Mar; 51(5):565-575. PubMed ID: 31960986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of meat and fat intake with liver disease and hepatocellular carcinoma in the NIH-AARP cohort.
    Freedman ND; Cross AJ; McGlynn KA; Abnet CC; Park Y; Hollenbeck AR; Schatzkin A; Everhart JE; Sinha R
    J Natl Cancer Inst; 2010 Sep; 102(17):1354-65. PubMed ID: 20729477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes medications and risk of HCC.
    Plaz Torres MC; Jaffe A; Perry R; Marabotto E; Strazzabosco M; Giannini EG
    Hepatology; 2022 Dec; 76(6):1880-1897. PubMed ID: 35239194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.
    Tokushige K; Hashimoto E; Horie Y; Taniai M; Higuchi S
    J Gastroenterol; 2011 Oct; 46(10):1230-7. PubMed ID: 21748549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin and other antidiabetic drugs and hepatocellular carcinoma risk: a nested case-control study based on Italian healthcare utilization databases.
    Bosetti C; Franchi M; Nicotra F; Asciutto R; Merlino L; La Vecchia C; Corrao G
    Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):771-8. PubMed ID: 26013675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma is the most common liver-related complication in patients with histopathologically-confirmed NAFLD in Japan.
    Akuta N; Kawamura Y; Arase Y; Saitoh S; Fujiyama S; Sezaki H; Hosaka T; Kobayashi M; Kobayashi M; Suzuki Y; Suzuki F; Ikeda K; Kumada H
    BMC Gastroenterol; 2018 Nov; 18(1):165. PubMed ID: 30400829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.